Skip to main content
TNDM
NASDAQ Industrial Applications And Services

Tandem 10-Q: Q3 Sales $283.7M, Net Loss $7.1M; Cash $443.1M, Debt $603.4M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$20
Mkt Cap
$1.252B
52W Low
$12.26
52W High
$29.65
52W Position info
63% above low
Off High info
33% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

TNDM sits 63% above its 52-week low of $12.26.

Summary

Tandem's Q3 10-Q confirms 14% sales growth to $283.7 million and a narrowed $7.1 million net loss, with $443.1 million of liquidity against $603.4 million of convertible notes and a supplier constraint expected to last into early 2027.


Key Events · Earnings and Guidance · TNDM

  • Q3 Sales Up 14% to $283.7M

    Worldwide sales rose to $283.7 million from $249.3 million, with U.S. sales of $191.0 million and international sales of $92.6 million; gross margin improved to 57% from 54%.

  • Net Loss Narrowed to $7.1M

    Net loss was $7.1 million, or $0.10 per share, versus $21.2 million a year earlier, helped by the absence of last year's $75.2 million IPR&D and $20.0 million litigation charges.

  • Liquidity $443.1M vs $603.4M Debt

    Cash and cash equivalents plus short-term investments totaled $443.1 million at September 30, 2026; convertible notes rose to $603.4 million net from $310.0 million at December 31, 2025 after the $300.0 million 0% 2032 notes.

  • Supplier Constraint Into Early 2027

    A key infusion set supplier's supply challenges have hit inventory and supply sales, and the company expects the constraints to persist through early 2027.


Analysis · TNDM · Industrial Applications And Services

The 10-Q confirms the quarter the 8-K previewed — sales up 14% to $283.7 million and the net loss narrowed to $7.1 million from $21.2 million — but it also carries the balance-sheet detail investors need to judge the story. Liquidity of $443.1 million (cash plus short-term investments) covers at least the next twelve months, against $603.4 million of convertible notes that nearly doubled after the February 2026 zero-coupon 2032 issuance. The offsetting risk is operational: a key infusion set supplier's constraints are now expected to persist through early 2027, capping supply sales, and the pharmacy-channel shift is still depressing upfront pump revenue while supply revenue scales. The filing also formalizes the CEO handover to Jeannette Bankes effective November 16, 2026, with a $10.0 million RSU award and $900,000 base salary.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TNDM was trading at $20.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $12.26 to $29.65. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TNDM - Latest Insights

TNDM
Nov 13, 2026, 8:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $17.59
Real-time Price: $17.13 info
Change: -$0.460 (-3%) info
Market Cap: $1.192B info
TNDM
Nov 05, 2026, 4:16 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $17.13 info
Change: -$3.10 (-15%) info
Market Cap: $1.192B info
TNDM
Nov 05, 2026, 4:08 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $21.00
Real-time Price: $17.13 info
Change: -$3.87 (-18%) info
Market Cap: $1.192B info
TNDM
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $17.99
Real-time Price: $17.13 info
Change: -$0.860 (-5%) info
Market Cap: $1.192B info
TNDM
Aug 06, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $17.50
Real-time Price: $17.13 info
Change: -$0.370 (-2%) info
Market Cap: $1.192B info